A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PCNA

Search Conditions:
Search Keyword : PCNA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PCNA
Appearance Frequency: 9545 time(s)
Long forms: 67

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
proliferating cell nuclear antigen
(9441 times)
Neoplasms
(1271 times)
VEGF (260 times)
BrdU (247 times)
TUNEL (226 times)
1983 Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues.
percutaneous needle aspiration
(10 times)
Pulmonary Medicine
(4 times)
CT (2 times)
PPN/M (2 times)
TBNA (2 times)
1988 Percutaneous needle aspiration biopsy of chest lesions. New instrument and new technique.
proliferating cells
(10 times)
Anatomy
(2 times)
alpha-SMA (2 times)
AcF (1 time)
ACL (1 time)
1994 Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases.
Pollination constant and non-astringent
(6 times)
Botany
(3 times)
PAs (3 times)
C-PCNA (2 times)
ANR (1 time)
2009 Expression balances of structural genes in shikimate and flavonoid biosynthesis cause a difference in proanthocyanidin accumulation in persimmon (Diospyros kaki Thunb.) fruit.
patterns of cyclin
(5 times)
Neoplasms
(2 times)
AMA (1 time)
PEG (1 time)
1985 S-phase patterns of cyclin (PCNA) antigen staining resemble topographical patterns of DNA synthesis. A role for cyclin in DNA replication?
PCNA-Ub
(4 times)
Molecular Biology
(2 times)
TLS (3 times)
CPD (1 time)
FA (1 time)
2011 PCNA ubiquitination is important, but not essential for translesion DNA synthesis in mammalian cells.
Primary cutaneous nodular amyloidosis
(4 times)
Dermatology
(3 times)
SLE (1 time)
SS (1 time)
Th (1 time)
2009 Primary cutaneous nodular amyloidosis: case report and review of the literature.
polycarbamate nucleic acids
(3 times)
Chemistry
(2 times)
GO (1 time)
2010 Design, synthesis and DNA/RNA binding studies of nucleic acids comprising stereoregular and acyclic polycarbamate backbone: polycarbamate nucleic acids (PCNA).
proliferation factor
(3 times)
Medicine
(1 time)
AR (1 time)
CP (1 time)
Dio-2 (1 time)
2009 Mouririelliptica: validation of gastroprotective, healing and anti-Helicobacter pylori effects.
10  proliferation immunohistochemistry
(2 times)
Neoplasms
(1 time)
--- 1998 Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.
11  cell proliferation related proteins
(1 time)
Toxicology
(1 time)
CDK2 (1 time)
2021 Effect of fenofibrate on proliferation of SMMC-7721 cells via regulating cell cycle.
12  cell-proliferating antigen
(1 time)
b.wt (1 time)
BA (1 time)
FPN (1 time)
2021 Ameliorative Effects of Boswellic Acid on Fipronil-Induced Toxicity: Antioxidant State, Apoptotic Markers, and Testicular Steroidogenic Expression in Male Rats.
13  DNA-polymerase sliding clamp
(1 time)
Science
(1 time)
--- 2013 Putative antirecombinase Srs2 DNA helicase promotes noncrossover homologous recombination avoiding loss of heterozygosity.
14  factor--proliferating cellular antigen
(1 time)
Endocrinology
(1 time)
BAX (1 time)
EGF (1 time)
GC (1 time)
2013 Luteinizing hormone, insulin like growth factor-1, and epidermal growth factor stimulate vascular endothelial growth factor production in cultured bubaline granulosa cells.
15  long-patch
(1 time)
Cell Biology
(1 time)
BER (1 time)
2021 Cytoskeleton integrity influences XRCC1 and PCNA dynamics at DNA damage.
16  non-proliferative nuclei by detection of a proliferation marker
(1 time)
Natural Science Disciplines
(1 time)
IUGR (1 time)
2019 The Density of Cell Nuclei at the Materno-Fetal Exchange Barrier is Sexually Dimorphic in Normal Placentas, but not in IUGR.
17  Palliative Care Needs Assessment
(1 time)
Geriatrics
(1 time)
HRQoL (1 time)
2022 Evaluation design of the patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard (InAdvance): a randomised controlled trial.
18  parameters studied were body weights; histopathological examination, immunohistochemistry
(1 time)
Pharmacology
(1 time)
BPH (1 time)
2016 Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
19  pathway, and activates expression of cell nuclear antigen
(1 time)
Physiology
(1 time)
IGF-I (1 time)
NGF (1 time)
PCA (1 time)
2016 Nerve Regeneration Potential of Protocatechuic Acid in RSC96 Schwann Cells by Induction of Cellular Proliferation and Migration through IGF-IR-PI3K-Akt Signaling.
20  Patient Care Needs Assessment
(1 time)
Nursing
(1 time)
RN/RPN (1 time)
UEP (1 time)
2010 Development and evaluation of an RN/RPN utilization toolkit.
21  patterns and sequence of cyclin
(1 time)
Hematology
(1 time)
AMA (1 time)
1987 PCNA (cyclin) autoantibodies and monoclonal antibodies reveal similar patterns of cyclin (PCNA) antigen staining in human cultured cells.
22  PCNA and MIB-1 were in the middle and upper layers
(1 time)
Neoplasms
(1 time)
--- 1995 Cell proliferation patterns and p53 expression in gastric dysplasia.
23  PCNA index and of AgNOR number with the histological grade
(1 time)
General Surgery
(1 time)
NORs (1 time)
1993 Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
24  PCNA labeling indices
(1 time)
Pathology
(1 time)
--- 1996 Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
25  PCNA score
(1 time)
Neoplasms
(1 time)
CC (1 time)
1993 The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma.
26  PCNA-positive
(1 time)
Cardiology
(1 time)
AKI (1 time)
IRI (1 time)
2016 17beta-Estradiol Accelerated Renal Tubule Regeneration in Male Rats After Ischemia/Reperfusion-Induced Acute Kidney Injury.
27  PCNA-tot
(1 time)
Neoplasms
(1 time)
IdUrd (1 time)
NHL (1 time)
1997 Flow cytometric evaluation of proliferating cell nuclear antigen expression in human hematopoietic malignancies.
28  PCNA/cyclin
(1 time)
Neoplasms
(1 time)
P-gp (1 time)
1993 PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective study.
29  PD-1 inhibited NK cells treatment group: 13.66
(1 time)
Medicine
(1 time)
GBM (1 time)
LDH (1 time)
MRI (1 time)
2015 The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells.
30  peptides associated with proliferation
(1 time)
Endocrinology
(1 time)
IGFBP-3 (1 time)
PKA (1 time)
TGF-2beta (1 time)
2004 Thrombopoietin regulates proliferation, apoptosis, secretory activity and intracellular messengers in porcine ovarian follicular cells: involvement of protein kinase A.
31  percentage of cell nuclear antigen
(1 time)
Otolaryngology
(1 time)
EHL (1 time)
1997 Quantitative pathology of laryngeal epithelial hyperplastic lesions.
32  percentage of cells staining for proliferation marker
(1 time)
Natural Science Disciplines
(1 time)
Fsp-Cre (1 time)
N-WASP (1 time)
2016 Conditional knockout of N-WASP in mouse fibroblast caused keratinocyte hyper proliferation and enhanced wound closure.
33  percutaneous approach
(1 time)
General Surgery
(1 time)
ICA (1 time)
PPL (1 time)
TBNA (1 time)
2000 Integration of TBNA and TCNA in the diagnosis of peripheral lung nodules. Influence on staging.
34  Person-Centered Network App
(1 time)
PSSNs (1 time)
SOCs (1 time)
2018 Social Connectedness in Family Social Support Networks: Strengthening Systems of Care for Children with Special Health Care Needs.
35  PfuPCNA
(1 time)
Biochemistry
(1 time)
BER (1 time)
UDG (1 time)
2009 Studies on the base excision repair (BER) complex in Pyrococcus furiosus.
36  phosphorylated CREB-1, markers of proliferation
(1 time)
Biology
(1 time)
CREB-1 M1 (1 time)
CREB-1 WT (1 time)
EIA (1 time)
2019 The involvement of the phosphorylatable and nonphosphorylatable transcription factor CREB-1 in the control of human ovarian cell functions.
37  Polycyclic Nuclear Antigen
(1 time)
Cell Biology
(1 time)
CT scFv (1 time)
CTAs (1 time)
2003 Biopanning of single-chain antibodies expressing phages reveals distinct expression patterns of angiogenic and arteriogenic vessels.
38  positively charged gold nanoparticle
(1 time)
Biomedical Engineering
(1 time)
Hb (1 time)
MWCNT (1 time)
2008 Electrochemical nitrite biosensor based on the immobilization of hemoglobin on an electrode modified by multiwall carbon nanotubes and positively charged gold nanoparticle.
39  Post-Conflict Needs Assessment
(1 time)
Military Medicine
(1 time)
DRC (1 time)
SGBV (1 time)
2011 Evaluation of medical supplies essential for the care of survivors of sex- and gender-based violence in post-conflict Eastern Democratic Republic of Congo.
40  pp-siRNA/CLD/DNCA/cRAD
(1 time)
Molecular Biology
(1 time)
CLD (1 time)
PCNR (1 time)
pp-siRNA (1 time)
2019 Construction of a Targeting Nanoparticle of 3',3″-Bis-Peptide-siRNA Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD.
41  presence of type II cell markers and cellular proliferation markers
(1 time)
Histology
(1 time)
SP-A (1 time)
1997 The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas.
42  present study, we used immunohistochemistry with antiproliferating cell nuclear antigen
(1 time)
Medicine
(1 time)
--- 1993 Localization of proliferating cell nuclear antigen in aural cholesteatoma.
43  preventing the decreased in cell proliferative marker
(1 time)
Biochemistry
(1 time)
DM (1 time)
MA (1 time)
2021 Myristic acid defends against testicular oxidative stress, inflammation, apoptosis: Restoration of spermatogenesis, steroidogenesis in diabetic rats.
44  Preventive Cardiovascular Nurses Association
(1 time)
Cardiology
(1 time)
--- 2009 Cardiovascular risk factors and lifestyle habits among preventive cardiovascular nurses.
45  profilic nucleic antigen
(1 time)
Medicine
(1 time)
DCIS (1 time)
2002 [Markers of ductal carcinoma in situ].
46  proliferating cell nuclear antigen immunostained hepatic nuclei
(1 time)
General Surgery
(1 time)
i.p (1 time)
QIA (1 time)
1994 Does preoperative chemotherapy for hepatic tumors have an adverse effect on hepatic proliferation after delayed liver resection?
47  Proliferating cell nuclear antigen immunostaining
(1 time)
Neoplasms
(1 time)
PhIP (1 time)
1998 Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets.
48  proliferating cell nuclear antigen labeling index, LI
(1 time)
Neoplasms
(1 time)
RIF-1 (1 time)
2005 Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo.
49  proliferating epithelial cells
(1 time)
Neoplasms
(1 time)
alphaSMA (1 time)
2007 Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model.
50  proliferating germ cells
(1 time)
--- 2022 Proliferation and Apoptosis of Cat (Felis catus) Male Germ Cells during Breeding and Non-Breeding Seasons.
51  proliferating hepatocyte activity
(1 time)
Gastroenterology
(1 time)
BMI (1 time)
CHC (1 time)
HCV (1 time)
2006 Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
52  proliferation activity
(1 time)
Reproduction
(1 time)
--- 2008 Chorioallantoic placentation in Galea spixii (Rodentia, Caviomorpha, Caviidae).
53  proliferation activity marker
(1 time)
Medicine
(1 time)
MEC (1 time)
2000 Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands.
54  proliferation associated
(1 time)
Neoplasms
(1 time)
--- 1995 Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors.
55  proliferation marker, such as cyclin
(1 time)
Dermatology
(1 time)
--- 1995 Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
56  proliferation, using antiproliferating cell nuclear antigen
(1 time)
Neoplasms
(1 time)
--- 1995 Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index.
57  proliferation-associated gene
(1 time)
Pharmacology
(1 time)
AS (1 time)
DAA (1 time)
DM (1 time)
2018 HOXA11-AS regulates diabetic arteriosclerosis-related inflammation via PI3K/AKT pathway.
58  proliferation-associated nuclear protein
(1 time)
Hematology
(1 time)
BM (1 time)
i.v (1 time)
ME (1 time)
1992 Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.
59  proliferation-associated nuclear proteins Ki-67, cyclin
(1 time)
Cell Biology
(1 time)
7-AMD (1 time)
1991 Changes in cell nuclei during S phase: progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, cyclin (PCNA), p105, and p34.
60  proliferation-related molecule
(1 time)
Endocrinology
(1 time)
HDAC (1 time)
ROS (1 time)
2015 HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways.
61  promoting cell proliferation
(1 time)
Endocrinology
(1 time)
--- 2018 Direct effects of neuropeptide nesfatin-1 on testicular spermatogenesis and steroidogenesis of the adult mice.
62  pronuclear cell antigen
(1 time)
Otorhinolaryngologic Diseases
(1 time)
--- 2018 Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.
63  Protein covariation network analysis
(1 time)
Biochemistry
(1 time)
ASK1 (1 time)
PD (1 time)
ST (1 time)
2015 MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model.
64  protein expression of cell nuclear antigen
(1 time)
Complementary Therapies
(1 time)
IGF-I (1 time)
siRNA (1 time)
2009 RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF-I.
65  protein, estrogen receptor, cathepsin D and low growth fraction
(1 time)
Pathology
(1 time)
CD (1 time)
ER (1 time)
IPCs (1 time)
1998 Correlated expression of BCL-2 protein, estrogen receptor, cathepsin D and low growth fraction (PCNA) in intracystic papillary breast carcinoma.
66  proton-coupled nucleophilic attack
(1 time)
Chemistry
(1 time)
--- 2015 Discussing endogenous NO(•)/HNO interconversion aided by phenolic drugs and vitamins.
67  pups and subjected to histomorphometric analysis for proliferation
(1 time)
Medicine
(1 time)
SSRIs (1 time)
2015 Effects of Citalopram on Sutural and Calvarial Cell Processes.